PTBP1-dependent Regulation of USP5 Alternative RNA Splicing Plays a Role in Glioblastoma Tumorigenesis

Por Izaguirre, Daisy I., Zhu, Wen, Hai, Tao, Cheung, Hannah C., Krahe, Ralf, Cote, Gilbert J.
Publicado em 2011

Poor survival with wild-type TP53 ovarian cancer?

Por Wong, Kwong-Kwok, Izaguirre, Daisy I., Kwan, Suetyan, King, Erin R., Deavers, Michael T., Sood, Anil K., Mok, Samuel C., Gershenson, David M.
Publicado em 2013

PAX2 Expression in Ovarian Cancer

Por Song, Huijuan, Kwan, Suet-Yan, Izaguirre, Daisy I., Zu, Zhifei, Tsang, Yvonne T., Tung, Celestine S., King, Erin R., Mok, Samuel C., Gershenson, David M., Wong, Kwong-Kwok
Publicado em 2013

Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas

Por Crane, Erin K., Kwan, Suet-Yan, Izaguirre, Daisy I., Tsang, Yvonne T. M., Mullany, Lisa K., Zu, Zhifei, Richards, JoAnne S., Gershenson, David M., Wong, Kwong-Kwok
Publicado no PLoS One (2015)

Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells

Por Kwan, Suet-Yan, Cheng, Xuanjin, Tsang, Yvonne T.M., Choi, Jong-Sun, Kwan, Suet-Ying, Izaguirre, Daisy I., Kwan, Hoi-Shan, Gershenson, David M., Wong, Kwong-Kwok
Publicado no Oncotarget (2016)